BOLT BIOTHERAPEUTICS INC shareholders Q4 2022

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 45 filers reported holding BOLT BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

BOLT BIOTHERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$2,458,9071.07%
Nan Fung Group Holdings Ltd 1,166,952$1,517,0381.04%
Vivo Capital, LLC 3,871,291$5,0330.58%
Hawkeye Capital Management, LLC 415,039$539,5510.50%
Newtyn Management, LLC 1,150,000$1,495,0000.31%
Samsara BioCapital, LLC 1,049,153$1,363,8990.29%
Sofinnova Investments, Inc. 2,754,437$3,580,7680.21%
Privium Fund Management (UK) Ltd 116,516$151,4710.12%
Board of Trustees of The Leland Stanford Junior University 719,546$935,5110.10%
TANG CAPITAL MANAGEMENT LLC 400,000$520,0000.08%
Oasis Management Co Ltd. 280,000$364,0000.07%
Marquette Asset Management, LLC 97,835$127,1860.04%
Orbimed Advisors 771,059$1,002,3770.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 187,600$243,8800.01%
Eversept Partners, LP 31,172$40,5240.00%
Assenagon Asset Management S.A. 225,816$2940.00%
Citadel Advisors 2,752,162$3,577,8100.00%
Renaissance Technologies 441,539$5740.00%
Ergoteles LLC 28,507$37,0590.00%
WELLS FARGO & COMPANY/MN 149$1940.00%
External links

This page lists BOLT BIOTHERAPEUTICS INC's shareholders in Q4 2022. To view BOLT BIOTHERAPEUTICS INC's shareholder history, click here.